Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2020 | Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30-Expressing Non-Hodgkin Lymphomas: Results of a Multicenter, Open-Labeled Phase II Trial | CANCER RESEARCH AND TREATMENT |